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Introduction
Mast cells, key effector cells of allergic and innate immune
responses, have recently been reported to be an important
source of IL-1ß in patients with autoinflammatory condi-
tions such as cryopyrin-associated-periodic-fever syn-
dromes (CAPS). CAPS patients show IL-1beta-driven
systemic inflammation together with non-histamine
dependent urticarial rash, which are caused by activating
mutations of the inflammasome, a multiprotein oligomer
responsible for the initiation of inflammatory responses to
pathogens.
Objectives
To determine if mast cells can produce and release IL-1ß
in response to pathogenic signals that target the inflamma-
somes NLRP3, NLRC4, or AIM2.
Methods
Peritoneal mast cells (PMCs) were obtained through
lavage from adult (>8 weeks) C57BL/6 mice and WBB6F1
Kit+/+ mice, purified via CD117+ bead selection (>96 %
purity) and cultured for 7-14 days. 105 cells/well were
primed with LPS (100ng/ml) for 15 hrs. Then the PMCs
were stimulated with 10 µM Nigericin (NLRP3), 5mM
ATP (NLRP3), 100µM R837 (NLRP3) for 45 min or for
4 hours with 600 ng Flagellin (NLRC4) transfected with
DOTAP or 200 ng polydAdT (AIM2) transfected with
Lipofectamine. IL-1 beta production was measured in the
supernatants by Elisa.
Results
PMCs produced significant amounts (mean ± SEM) of
IL-1ß upon stimulation with Nigericin (467 ± 41pg/ml),
ATP (152 ± 88pg/ml), R837 (21 ± 2 pg/ml), Flagellin
(245 ± 44pg/ml) and polydAdT (571 ± 194pg/ml) as
compared to no stimuli (7,1 ± 0,8 pg/ml) only.
Conclusion
We show that mouse mast cells incubated with inflamma-
some activators produce significant amounts of IL-1ß ex
vivo. Our data suggest that inflammasome-driven mast
cell activation and subsequent IL-1ß production and
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